#1 Clinical Trials Search in Europe

Chlortalidone

Chlortalidone is a thiazide-like diuretic medication that has been studied in several clinical trials for treating hypertension (high blood pressure) and kidney-related conditions. This article summarizes key findings from recent clinical trials investigating the efficacy and safety of chlortalidone for various medical uses, particularly its effects on blood pressure control and kidney function.

Table of Contents

What is Chlortalidone?

Chlortalidone, also known by brand names such as Thalitone or Hygroton, is a medication that belongs to a class of drugs called thiazide-like diuretics[1]. Diuretics are often referred to as “water pills” because they help your body get rid of excess water and salt through urine. Chlortalidone is similar to thiazide diuretics but has some unique properties that make it effective for treating various conditions.

Uses of Chlortalidone

Chlortalidone is primarily used to treat the following conditions:

  • Hypertension (High Blood Pressure): This is the most common use of chlortalidone. It helps lower blood pressure by reducing the amount of water in your body and relaxing blood vessels[1].
  • Edema (Fluid Retention): Chlortalidone can help reduce swelling caused by conditions like heart failure or kidney disease[2].
  • Chronic Kidney Disease (CKD): In patients with CKD, chlortalidone may be used to manage fluid balance and blood pressure[2].
  • Hypercalciuria (High Calcium in Urine): Some studies have explored the use of chlortalidone to reduce calcium excretion in urine, which may be beneficial for certain patients, including those with Type 1 Diabetes[3].

How Chlortalidone Works

Chlortalidone works by affecting the way your kidneys handle salt and water. Specifically, it:

  • Increases the amount of sodium and water excreted in urine
  • Reduces the volume of blood in your body, which helps lower blood pressure
  • May help decrease calcium excretion in urine (in some cases)

By reducing fluid volume in the body, chlortalidone can help alleviate symptoms of fluid overload, which is common in conditions like heart failure and advanced kidney disease[4].

Dosage and Administration

Chlortalidone is typically taken orally (by mouth) once daily. The dosage can vary depending on the condition being treated and individual patient factors. Some common dosages observed in clinical trials include:

  • 12.5 mg to 25 mg daily for hypertension[1]
  • 25 mg to 100 mg daily for advanced chronic kidney disease[4]

It’s important to note that your doctor will determine the right dose for you based on your specific condition and how you respond to the medication. Never adjust your dose without consulting your healthcare provider.

Effectiveness of Chlortalidone

Chlortalidone has been shown to be effective in several clinical studies:

  • For hypertension, chlortalidone can significantly reduce blood pressure when used alone or in combination with other medications[1].
  • In patients with chronic kidney disease, chlortalidone may help manage fluid overload and improve blood pressure control[4].
  • Some studies suggest that chlortalidone might be beneficial in reducing urinary calcium excretion in certain patients, such as those with Type 1 Diabetes[3].

Potential Side Effects

Like all medications, chlortalidone can cause side effects. Some potential side effects include:

  • Electrolyte imbalances: Chlortalidone can affect the levels of potassium, sodium, and other electrolytes in your body. Your doctor will likely monitor these levels with blood tests[5].
  • Dehydration: Because chlortalidone increases urine output, it can sometimes lead to dehydration. It’s important to stay well-hydrated while taking this medication[5].
  • Dizziness or lightheadedness: Especially when you first start taking the medication or if the dose is increased[1].
  • Changes in blood sugar levels: Chlortalidone may affect blood sugar control in some patients, particularly those with diabetes[3].

Always report any unusual symptoms or side effects to your healthcare provider.

Ongoing Research

Researchers continue to study chlortalidone to better understand its effects and potential uses. Some areas of ongoing research include:

  • Its use in combination with other medications for treating resistant hypertension[6].
  • Its effectiveness in managing fluid overload in patients with advanced chronic kidney disease[4].
  • Its potential benefits in reducing urinary calcium excretion in patients with Type 1 Diabetes[3].

These ongoing studies may provide more insights into the optimal use of chlortalidone in various patient populations.

Study Focus Key Findings Patient Population Dosage
Hypertension Treatment Chlortalidone effectively lowered blood pressure, especially when combined with other medications like azilsartan medoxomil Adults with essential hypertension 25 mg daily
Chronic Kidney Disease Compared effects on left ventricular mass and arterial stiffness with spironolactone Patients with stage 3 chronic kidney disease 25 mg daily
Kidney Transplant Recipients Investigated efficacy and safety for treating resistant hypertension in transplant patients Kidney transplant recipients with resistant hypertension 12.5-25 mg daily based on previous furosemide dose
Ethnicity-based Response Examined differences in antihypertensive response among various ethnic groups Diverse ethnic populations including White, Black, and South Asian participants 25 mg daily
Combination Therapy Studied in combination with other drugs like amiloride and spironolactone for enhanced blood pressure control Patients with uncontrolled hypertension 25 mg daily as part of combination therapy

FAQ

  • What is chlortalidone used for in clinical trials? Chlortalidone is primarily studied for treating hypertension (high blood pressure), both alone and in combination with other medications. It has also been investigated for its effects on kidney function in patients with chronic kidney disease and kidney transplant recipients.
  • How does chlortalidone compare to other blood pressure medications? Clinical trials have compared chlortalidone to other antihypertensive drugs like spironolactone and amlodipine. For example, one study examined the effects of chlortalidone versus spironolactone on left ventricular mass in patients with chronic kidney disease.
  • What are the potential side effects of chlortalidone? Common side effects monitored in clinical trials include changes in electrolyte levels (particularly potassium and sodium), effects on kidney function, and impacts on blood sugar control. Researchers closely monitor these parameters to ensure patient safety during trials.
  • How is chlortalidone administered in clinical trials? In most trials, chlortalidone is given orally as a tablet, typically at doses ranging from 12.5 mg to 25 mg daily. Some studies adjust the dose based on patient response or compare different dosing regimens.
  • What types of patients are included in chlortalidone clinical trials? Clinical trials have included patients with essential hypertension, chronic kidney disease, kidney transplant recipients, and those with resistant hypertension. Some studies focus on specific ethnic groups or age ranges to understand how the medication affects different populations.

Ongoing Clinical Trials on Chlortalidone

  • Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Comparison of ivabradine, atenolol, and metoprolol for heart rate control in patients with ischemic heart disease before cardiac CT examination

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study of flecainide alone or with beta-blockers or calcium channel blockers and quinidine for treating ventricular arrhythmias in patients with Andersen-Tawil syndrome and MEPPC

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effects of Bisoprolol Fumarate, Hydrochlorothiazide, and Metoprolol in Patients with Idiopathic Ventricular Fibrillation After Cardiac Arrest

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effects of Metoprolol, Prasugrel, and Carbasalate Calcium in Patients with Spontaneous Coronary Artery Dissection

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Chlortalidone: A thiazide-like diuretic medication used to treat high blood pressure and fluid retention. It works by helping the kidneys remove excess salt and water from the body.
  • Hypertension: High blood pressure, a condition where the force of blood against artery walls is consistently too high, which can lead to various health problems if left untreated.
  • Chronic Kidney Disease (CKD): A condition characterized by gradual loss of kidney function over time, often categorized into stages based on the glomerular filtration rate (GFR).
  • Left Ventricular Mass: The weight of the left ventricle of the heart, which can increase due to conditions like hypertension and is associated with increased cardiovascular risk.
  • Glomerular Filtration Rate (GFR): A measure of how well the kidneys are filtering waste from the blood, used to determine kidney function and stage of chronic kidney disease.
  • Ambulatory Blood Pressure Monitoring (ABPM): A method of measuring blood pressure at regular intervals over a 24-hour period as a person goes about their daily activities.
  • Resistant Hypertension: High blood pressure that remains above target levels despite the use of three or more antihypertensive medications.
  • Diuretic: A type of medication that increases urine production and helps remove excess fluid from the body.
  • Electrolytes: Minerals in the blood and other bodily fluids that carry an electric charge and are essential for various bodily functions.
  • Azilsartan Medoxomil: An angiotensin II receptor blocker used to treat high blood pressure, often studied in combination with chlortalidone.

References

  1. https://clinicaltrials.gov/study/NCT00591773
  2. https://clinicaltrials.gov/study/NCT02502981
  3. https://clinicaltrials.gov/study/NCT03325114
  4. https://clinicaltrials.gov/study/NCT03923933
  5. https://clinicaltrials.gov/study/NCT04393493
  6. https://clinicaltrials.gov/study/NCT02847338